首页> 外文期刊>Journal of molecular medicine: Official organ of the "Gesellschaft Deutscher Naturforscher und Arzte." >Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits.
【24h】

Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits.

机译:研究细胞周期蛋白依赖性激酶抑制剂1C和细胞周期蛋白依赖性激酶4基因与2型糖尿病的关系以及相关的定量性状。

获取原文
获取原文并翻译 | 示例
           

摘要

CDK4 is involved in the regulation of body weight, pancreatic beta-cell proliferation, insulin responsiveness, and diabetes pathogenesis. CDK4 activity is inhibited by CDKN1C, which is regulated by insulin. In addition, CDKN1C plays an important role in beta-cell proliferation and is involved in the pathogenesis of the Beckwith-Wiedemann syndrome, a disorder characterized by neonatal hyperinsulinaemic hypoglycaemia and pre- and post-natal overgrowth. The aim of this study was to investigate if variations in the proximal promoter and the coding region of the CDKN1C and CDK4 genes are associated with type 2 diabetes or changes in related quantitative phenotypes among glucose-tolerant subjects. Mutation analyses of the two genes in 62 type 2 diabetic patients resulted in the discovery of seven variants of CDKN1C and two variants of CDK4. In a case-control study comprising 717 type 2 diabetic patients and 518 glucose-tolerant subjects the most frequent variants did not show any difference in allele frequencies between the type 2 diabetic patients and the control subjects. However, in two genotype-quantitative trait correlation studies involving 206 glucose-tolerant offspring of type 2 diabetic patients and 359 young, healthy subjects the CDKN1C del171APVA variant associated with increased birth weight (P=0.05 and P=0.05). Furthermore, the same variant tended to be associated with decreased basal glucose oxidation among 16 genotypically discordant dizygotic twins (P=0.03). In a genotype-quantitative trait study involving 500 middle-aged glucose-tolerant subjects the CDK4 IVS2-31G-->A variant was associated with an increased waist circumference (P=0.03) and waist-to-hip ratio (P=0.02) and altered fasting plasma glucose (P=0.03). However, these later findings could not be replicated in additional studies. In conclusion, variants in CDKN1C may contribute to the inter-individual variation in birth weight.
机译:CDK4参与体重,胰腺β细胞增殖,胰岛素反应性和糖尿病发病机制的调节。 CDKN1C抑制CDK4活性,而CDKN1C受胰岛素调节。此外,CDKN1C在β细胞增殖中起重要作用,并参与Beckwith-Wiedemann综合征的发病机理,该综合征以新生儿高胰岛素血症性低血糖症以及产前和产后过度生长为特征。这项研究的目的是调查在糖耐量受试者中,近端启动子以及CDKN1C和CDK4基因编码区的变化是否与2型糖尿病或相关定量表型的变化有关。对62位2型糖尿病患者中两个基因的突变分析导致发现CDKN1C的七个变体和CDK4的两个变体。在一项包括717位2型糖尿病患者和518位葡萄糖耐量受试者的病例对照研究中,最常见的变体在2型糖尿病患者和对照受试者之间没有显示等位基因频率的任何差异。但是,在两项涉及206名2型糖尿病患者的耐糖后代和359名年轻健康受试者的基因型-定量性状相关研究中,CDKN1C del171APVA变异与出生体重增加相关(P = 0.05和P = 0.05)。此外,在16个基因型不一致的同卵双生双胞胎中,相同的变异体往往与基础葡萄糖氧化降低有关(P = 0.03)。在一项涉及500名中年葡萄糖耐量受试者的基因型定量性状研究中,CDK4 IVS2-31G-> A变异与腰围增加(P = 0.03)和腰臀比(P = 0.02)相关并改变了空腹血糖(P = 0.03)。但是,这些后来的发现无法在其他研究中重复。总之,CDKN1C的变异可能会导致出生体重的个体差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号